Home > Insider Trading > Filing (0001179110-10-016186)

Filing Details

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
815094	Abiomed Inc	ABMD	Surgical & Medical Instruments & Apparatus (3841)	042743260

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1021038	A Henri Termeer	C/O Abiomed, Inc. 22 Cherry Hill Drive Danvers MA 01923		Yes	No	No	No

Reported Non-Derivative Transactions

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock, $.01 Par Value	Disposition	2010-11-15	7,296	$11.93	2,012,807	No	4	S	Indirect	By Genzyme Corporation

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	S	Indirect	By Genzyme Corporation

Reported Non-Derivative Holdings

Sec. Name	Remaning Holdings	Nature of Ownership	Explanation
Common Stock, $0.01 Par Value	60,100	Direct

Reported Derivative Holdings

Sec. Name	Sec. Type	Price	Date	Expiration Date	Amount	Remaning Holdings	Nature of Ownership
Common Stock	Stock Option (right to buy)	$19.69	2001-08-09	2010-08-09	5,000	5,000	Direct
Common Stock	Stock Option (right to buy)	$18.40	2002-08-08	2012-08-08	5,000	5,000	Direct
Common Stock	Stock Option (right to buy)	$4.71	2003-08-06	2013-08-06	5,000	5,000	Direct
Common Stock	Stock Option (right to buy)	$5.15	2004-08-13	2014-08-13	5,000	5,000	Direct
Common Stock	Stock Option (right to buy)	$10.41	2005-08-11	2014-08-11	8,000	8,000	Direct
Common Stock	Stock Option (right to buy)	$10.06	2006-08-09	2015-08-10	8,000	8,000	Direct
Common Stock	Stock Option (right to buy)	$13.21	2007-08-08	2016-08-09	8,000	8,000	Direct
Common Stock	Stock option (right to buy)	$12.69	2008-08-13	2017-08-08	8,000	8,000	Direct
Common Stock	Stock Option (right to buy)	$18.63	2009-08-12	2018-08-13	8,000	8,000	Direct
Common Stock	Stock Option (right to buy)	$7.67	2010-08-11	2019-08-12	12,000	12,000	Direct
Common Stock	Stock Options (right to buy)	$9.99	2011-08-10	2020-08-11	12,000	12,000	Direct

Expiration Date	Amount	Remaning Holdings	Nature of Ownership
2010-08-09	5,000	5,000	Direct
2012-08-08	5,000	5,000	Direct
2013-08-06	5,000	5,000	Direct
2014-08-13	5,000	5,000	Direct
2014-08-11	8,000	8,000	Direct
2015-08-10	8,000	8,000	Direct
2016-08-09	8,000	8,000	Direct
2017-08-08	8,000	8,000	Direct
2018-08-13	8,000	8,000	Direct
2019-08-12	12,000	12,000	Direct
2020-08-11	12,000	12,000	Direct

Footnotes

Grant to reporting person of option to buy the number of shares of Common Stock set forth in Table II, Column 7, under the ABIOMED, Inc. 1989 Non-Qualified Stock Option Plan for Non-Employee Directors.
This option becomes exercisable in full on the date set forth in Table II, Column 6.
The reporting person disclaims beneficial ownership of these securities, and this report shall not be deemed an admission that the reporting person is the beneficial owner of such securities for the purposes of Section 16 or for any other purposes. The reporting person is the Chief Executive Officer of Genzyme Corporation.
Grant to reporting person of option to buy the number of shares of Common Stock set forth in Table II, Column 7, under the ABIOMED, Inc. 2000 Stock Incentive Plan.
Grant to reporting person of option to buy shares of Common Stock set forth in Table II, Column 7, under the ABIOMED, Inc. 2008 Stock Incentive Plan.
This price represents the weighted average sale price of multiple transactions on the reported date at prices that ranged between $11.90 and $11.99. Detailed information regarding the number of shares sold at each separate price will be provided upon request by the Commission staff, the Issuer, or a security holder of the Issuer.